Replies to post #176479 on Biotech Values

[DewDiligence]

Matt Herper’s musings on the MNK-QCOR deal, including the tax angle:

http://www.forbes.com/sites/matthewherper/2014/04/07/5-6-billion-questcor-deal-means-high-drug-prices-for-everybody/

[DewDiligence]

NYT piece on Acthar undisclosed AEs is not hurting QCOR or MNK today:

http://www.nytimes.com/2014/07/11/business/questcor-reveals-adverse-events-data-for-acthar-for-first-time.html

Both stocks are down less than 1%.

[DewDiligence]

MNK -18% on Citron tweet saying it has “more downside” than VRX:

http://finance.yahoo.com/news/mallinckrodt-plunges-citron-tweet-192751078.html